Harvey A Schwertner

Title: Harvey A Schwertner: Innovator in Medical Risk Prediction

Introduction

Harvey A Schwertner is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of medical diagnostics, particularly in predicting health risks associated with various diseases. With a total of 7 patents, Schwertner's work has the potential to impact patient care and treatment outcomes.

Latest Patents

Schwertner's latest patents include innovative methods for predicting health risks. One of his notable inventions is a method that utilizes bilirubin tests as risk predictors for systemic lupus erythematosus and psoriatic arthritis. This method identifies the risk of cancer mortality, rheumatoid arthritis, and other conditions by analyzing serum bilirubin levels. Lower serum bilirubin levels generally indicate an increased risk, while higher levels suggest a decreased risk. Another significant patent involves combined cholesterol and bilirubin tests as predictors for coronary artery disease (CAD). This method calculates a ratio using LDL-cholesterol, HDL-cholesterol, and serum total bilirubin, providing a weighted value for bilirubin in assessing CAD risk.

Career Highlights

Harvey A Schwertner is associated with the United States of America as represented by the Secretary of the Air Force. His work in this capacity has allowed him to focus on developing innovative medical diagnostic methods that can enhance patient care.

Collaborations

Some of Schwertner's notable coworkers include Joseph R Fischer, Jr and Johnathan Lloyd Kiel. Their collaboration has likely contributed to the advancement of his research and patent developments.

Conclusion

Harvey A Schwertner's contributions to medical diagnostics through his innovative patents demonstrate his commitment to improving health outcomes. His work in predicting health risks using bilirubin and cholesterol levels is paving the way for advancements in patient care.